Over half of the WHO guidelines published from 2014 to 2019 explicitly considered health equity issues: a cross-sectional survey.


Journal

Journal of clinical epidemiology
ISSN: 1878-5921
Titre abrégé: J Clin Epidemiol
Pays: United States
ID NLM: 8801383

Informations de publication

Date de publication:
11 2020
Historique:
received: 27 04 2020
revised: 23 06 2020
accepted: 16 07 2020
pubmed: 28 7 2020
medline: 6 3 2021
entrez: 28 7 2020
Statut: ppublish

Résumé

To evaluate how and to what extent health equity considerations are assessed in World Health Organization (WHO) guidelines. We evaluated WHO guidelines published between January 2014 and May 2019. Health equity considerations were assessed in relation to differences in baseline risk, importance of outcomes for socially disadvantaged populations, inclusion of health inequity as an outcome, equity-related subgroup analysis, and indirectness in each recommendation. We identified 111 WHO guidelines, and 54% (60 of 111) of these used the Evidence to Decision (EtD) framework. For the 60 guidelines using an EtD framework, the likely impact on health equity was supported by research evidence in 28% of the recommendations (94 of 332). Research evidence was mostly provided as differences in baseline risk (23%, 78/332). Research evidence less frequently addressed the importance of outcomes for socially disadvantaged populations (11%, 36/332), considered indirectness of the evidence for socially disadvantaged populations (2%, 5/332), considered health inequities as an outcome (2%, 5/332) and considered differences in the magnitude of effect in relative terms between disadvantaged and more advantaged populations (1%, 3/332). The provision of research evidence to support equity judgements in WHO guidelines is still suboptimal, suggesting the need for better guidance and more training.

Identifiants

pubmed: 32717312
pii: S0895-4356(20)30472-8
doi: 10.1016/j.jclinepi.2020.07.012
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

125-133

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Omar Dewidar (O)

Bruyère Research Institute, University of Ottawa, 85 Primrose Avenue, Ottawa, Ontario K1R 6M1, Canada; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, 600 Peter Morand Crescent, Ottawa, Ontario K1G 5Z3, Canada. Electronic address: Odewi090@uottawa.ca.

Phillip Tsang (P)

Bruyère Research Institute, University of Ottawa, 85 Primrose Avenue, Ottawa, Ontario K1R 6M1, Canada.

Montserrat León-García (M)

Iberoamerican Cochrane Centre, Sant Pau Biomedical Research Institute (IIB Sant Pau), Carrer de Sant Antoni Maria Claret, 167, 08025 Barcelona, Spain.

Christine Mathew (C)

Bruyère Research Institute, University of Ottawa, 85 Primrose Avenue, Ottawa, Ontario K1R 6M1, Canada.

Alba Antequera (A)

Biomedical Research Institute Sant Pau (IIB Santpau), Universitat Autònoma de Barcelona, Carrer de Sant Quintí, 77, 08041 Barcelona, Spain.

Tejan Baldeh (T)

Department of Health Research Methodology, Evidence and Impact (HEI), McMaster University Faculty of Health Sciences, 1280 Main Street, Hamilton, Ontario L8S 4K1, Canada.

Elie A Akl (EA)

Department of Health Research Methodology, Evidence and Impact (HEI), McMaster University Faculty of Health Sciences, 1280 Main Street, Hamilton, Ontario L8S 4K1, Canada; Department of Internal Medicine, American University of Beirut, PO Box 11-0236, Riad El Solh, Beirut 1107 2020, Lebanon.

Pablo Alonso-Coello (P)

Iberoamerican Cochrane Centre, Sant Pau Biomedical Research Institute (IIB Sant Pau), Carrer de Sant Antoni Maria Claret, 167, 08025 Barcelona, Spain; CIBER de Epidemiología Clínica y Salud Pública (CIBERESP), Spain.

Jennifer Petkovic (J)

Bruyère Research Institute, University of Ottawa, 85 Primrose Avenue, Ottawa, Ontario K1R 6M1, Canada.

Thomas Piggott (T)

Department of Health Research Methodology, Evidence and Impact (HEI), McMaster University Faculty of Health Sciences, 1280 Main Street, Hamilton, Ontario L8S 4K1, Canada.

Kevin Pottie (K)

School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, 600 Peter Morand Crescent, Ottawa, Ontario K1G 5Z3, Canada; Department of Family Medicine, University of Ottawa, 600 Peter Morand Crescent Suite 201, Ottawa, Ontario K1G 5Z3, Canada; Department of Medicine, University of Ottawa Faculty of Medicine, Roger Guindon Hall, 451 Smyth Road #2044, Ottawa, Ontario K1H 8M5, Canada.

Holger Schünemann (H)

Department of Health Research Methodology, Evidence and Impact (HEI), McMaster University Faculty of Health Sciences, 1280 Main Street, Hamilton, Ontario L8S 4K1, Canada.

Peter Tugwell (P)

Department of Medicine, University of Ottawa Faculty of Medicine, Roger Guindon Hall, 451 Smyth Road #2044, Ottawa, Ontario K1H 8M5, Canada; Clinical Epidemiology Program, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, Ontario K1H 8L6, Canada; WHO Collaborating Centre for Knowledge Translation and Health Technology Assessment in Health Equity, Bruyère Research Institute, 85 Primrose Avenue, Ottawa, Ontario K1R 6M1, Canada.

Vivian Welch (V)

Bruyère Research Institute, University of Ottawa, 85 Primrose Avenue, Ottawa, Ontario K1R 6M1, Canada; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, 600 Peter Morand Crescent, Ottawa, Ontario K1G 5Z3, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH